AI Lung Cancer Screening, Built in Hong Kong for Asia
Caretia develops an AI-powered platform to detect lung cancer earlier via CT scans—starting in Hong Kong, with a mission to scale affordable screening across Asia and reduce healthcare burdens continent-wide.
Lung Cancer: Asia's Growing Crisis
Lung cancer tops cancer deaths in Hong Kong and is a leading killer across Asia, with early stages showing no symptoms—leading to late diagnoses amid rising cases in high-density urban populations. Low-dose CT (LDCT) enables early detection worldwide, but cost, access, and workflow issues limit screening from Hong Kong to Southeast Asia.
-
Over 1 in 4 cancer deaths from lung cancer in Hong Kong; similar trends burden Asia
-
Early detection boosts survival rates dramatically, yet screening reaches few
Caretia AI
Our AI analyzes lung CT scans to flag early lesions accurately and efficiently, trained on Hong Kong-specific data with plans to adapt for diverse Asian populations. It speeds up radiologist workflows, cuts costs, and expands screening to serve clinics and communities across Asia.
It works with 2 simple steps :
-
Upload LDCT scan
-
AI triages nodules instantly
Impact
Our goal is to help people in Asia at large by scaling AI-driven lung cancer screening: partnering with charities in Hong Kong to subsidize screenings for underprivileged groups, gathering data to refine our AI, and expanding to address Asia's lung cancer epidemic through accessible, cost-effective tools. This supports government goals for AI in cancer care, uniting tech, medicine, and policy from Hong Kong outward.
About CARETIA
Caretia is an AI medical imaging startup headquartered in Hong Kong, dedicated to early lung cancer detection through CT scans, aiming to provide affordable screening services across Asia.
We focus on improving early detection rates and alleviating healthcare burdens in densely populated urban areas.
Caretia's team consists of postgraduate students and alumni from The University of Hong Kong and The Chinese University of Hong Kong, specializing in medicine and artificial intelligence. This startup is currently incubated at Cyberport and supported by Hong Kong Science Park.